迈博药业有限公司（股票代码：02181，股票名称：迈博药业-B）于2026年4月2日披露2026年3月股份变动月报表。报告期截至2026年3月31日，公司注册股本总额保持在50,000,000,000股，面值每股0.0001美元，合计5,000,000美元，无任何变动。
\n\n截至报告期末，已发行股份总数为4,124,080,000股，与上月末一致。本月未进行新增发行、购回、注销或库藏股操作。股本结构维持稳定，公众持股量符合相关上市规则要求。
\n\n公司股份期权数量为72,670,876份，与上月末相同；报告期内未有新授、行使或注销等变动。截至报告期末，尚可发行或转让的股份期权数目与上月末保持一致。
\n\n本月报由公司秘书曾浩贤签署。公司确认遵守香港联交所《上市规则》的相关规定，截至3月底股本无变化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.